262 related articles for article (PubMed ID: 22800573)
21. Development of a single dose tetanus toxoid formulation based on polymeric microspheres: a comparative study of poly(D,L-lactic-co-glycolic acid) versus chitosan microspheres.
Jaganathan KS; Rao YU; Singh P; Prabakaran D; Gupta S; Jain A; Vyas SP
Int J Pharm; 2005 Apr; 294(1-2):23-32. PubMed ID: 15814228
[TBL] [Abstract][Full Text] [Related]
22. PLGA nanoparticles codeliver paclitaxel and Stat3 siRNA to overcome cellular resistance in lung cancer cells.
Su WP; Cheng FY; Shieh DB; Yeh CS; Su WC
Int J Nanomedicine; 2012; 7():4269-83. PubMed ID: 22904633
[TBL] [Abstract][Full Text] [Related]
23. Tumor Selective Silencing Using an RNAi-Conjugated Polymeric Nanopharmaceutical.
Svenson S; Case RI; Cole RO; Hwang J; Kabir SR; Lazarus D; Lim Soo P; Ng PS; Peters C; Shum P; Sweryda-Krawiec B; Tripathi S; van der Poll D; Eliasof S
Mol Pharm; 2016 Mar; 13(3):737-47. PubMed ID: 26835715
[TBL] [Abstract][Full Text] [Related]
24. Chitosan-modified poly(D,L-lactide-co-glycolide) nanospheres for improving siRNA delivery and gene-silencing effects.
Tahara K; Yamamoto H; Hirashima N; Kawashima Y
Eur J Pharm Biopharm; 2010 Mar; 74(3):421-6. PubMed ID: 20034563
[TBL] [Abstract][Full Text] [Related]
25. Mechanistic profiling of the siRNA delivery dynamics of lipid-polymer hybrid nanoparticles.
Colombo S; Cun D; Remaut K; Bunker M; Zhang J; Martin-Bertelsen B; Yaghmur A; Braeckmans K; Nielsen HM; Foged C
J Control Release; 2015 Mar; 201():22-31. PubMed ID: 25540904
[TBL] [Abstract][Full Text] [Related]
26. Modified nanoprecipitation method to fabricate DNA-loaded PLGA nanoparticles.
Niu X; Zou W; Liu C; Zhang N; Fu C
Drug Dev Ind Pharm; 2009 Nov; 35(11):1375-83. PubMed ID: 19832638
[TBL] [Abstract][Full Text] [Related]
27. Engineering of small interfering RNA-loaded lipidoid-poly(DL-lactic-co-glycolic acid) hybrid nanoparticles for highly efficient and safe gene silencing: A quality by design-based approach.
Thanki K; Zeng X; Justesen S; Tejlmann S; Falkenberg E; Van Driessche E; Mørck Nielsen H; Franzyk H; Foged C
Eur J Pharm Biopharm; 2017 Nov; 120():22-33. PubMed ID: 28756280
[TBL] [Abstract][Full Text] [Related]
28. Gene silencing activity of siRNA polyplexes based on biodegradable polymers.
Varkouhi AK; Lammers T; Schiffelers RM; van Steenbergen MJ; Hennink WE; Storm G
Eur J Pharm Biopharm; 2011 Apr; 77(3):450-7. PubMed ID: 21118719
[TBL] [Abstract][Full Text] [Related]
29. Phosphorylatable short peptide conjugated low molecular weight chitosan for efficient siRNA delivery and target gene silencing.
Kong F; Liu G; Sun B; Zhou S; Zuo A; Zhao R; Liang D
Int J Pharm; 2012 Jan; 422(1-2):445-53. PubMed ID: 22067703
[TBL] [Abstract][Full Text] [Related]
30. Chitosan-coated PLGA nanoparticles for DNA/RNA delivery: effect of the formulation parameters on complexation and transfection of antisense oligonucleotides.
Nafee N; Taetz S; Schneider M; Schaefer UF; Lehr CM
Nanomedicine; 2007 Sep; 3(3):173-83. PubMed ID: 17692575
[TBL] [Abstract][Full Text] [Related]
31. Facial amphipathic deoxycholic acid-modified polyethyleneimine for efficient MMP-2 siRNA delivery in vascular smooth muscle cells.
Kim D; Lee D; Jang YL; Chae SY; Choi D; Jeong JH; Kim SH
Eur J Pharm Biopharm; 2012 May; 81(1):14-23. PubMed ID: 22311297
[TBL] [Abstract][Full Text] [Related]
32. Gene silencing activity of siRNA polyplexes based on thiolated N,N,N-trimethylated chitosan.
Varkouhi AK; Verheul RJ; Schiffelers RM; Lammers T; Storm G; Hennink WE
Bioconjug Chem; 2010 Dec; 21(12):2339-46. PubMed ID: 21049986
[TBL] [Abstract][Full Text] [Related]
33. Paclitaxel loaded folic acid targeted nanoparticles of mixed lipid-shell and polymer-core: in vitro and in vivo evaluation.
Zhao P; Wang H; Yu M; Liao Z; Wang X; Zhang F; Ji W; Wu B; Han J; Zhang H; Wang H; Chang J; Niu R
Eur J Pharm Biopharm; 2012 Jun; 81(2):248-56. PubMed ID: 22446630
[TBL] [Abstract][Full Text] [Related]
34. Development and characterization of a new plasmid delivery system based on chitosan-sodium deoxycholate nanoparticles.
Cadete A; Figueiredo L; Lopes R; Calado CC; Almeida AJ; Gonçalves LM
Eur J Pharm Sci; 2012 Mar; 45(4):451-8. PubMed ID: 21986445
[TBL] [Abstract][Full Text] [Related]
35. Photochemical internalization for pDNA transfection: evaluation of poly(d,l-lactide-co-glycolide) and poly(ethylenimine) nanoparticles.
Gargouri M; Sapin A; Arıca-Yegin B; Merlin JL; Becuwe P; Maincent P
Int J Pharm; 2011 Jan; 403(1-2):276-84. PubMed ID: 21044878
[TBL] [Abstract][Full Text] [Related]
36. Incorporation of PLGA nanoparticles into porous chitosan-gelatin scaffolds: influence on the physical properties and cell behavior.
Nandagiri VK; Gentile P; Chiono V; Tonda-Turo C; Matsiko A; Ramtoola Z; Montevecchi FM; Ciardelli G
J Mech Behav Biomed Mater; 2011 Oct; 4(7):1318-27. PubMed ID: 21783141
[TBL] [Abstract][Full Text] [Related]
37. A novel hybrid delivery system: polymer-oil nanostructured carrier for controlled delivery of highly lipophilic drug all-trans-retinoic acid (ATRA).
Narvekar M; Xue HY; Wong HL
Int J Pharm; 2012 Oct; 436(1-2):721-31. PubMed ID: 22850294
[TBL] [Abstract][Full Text] [Related]
38. Fabrication and characterization of PLGA/HAp composite scaffolds for delivery of BMP-2 plasmid DNA.
Nie H; Wang CH
J Control Release; 2007 Jul; 120(1-2):111-21. PubMed ID: 17512077
[TBL] [Abstract][Full Text] [Related]
39. Comparison of chitosan/siRNA and trimethylchitosan/siRNA complexes behaviour in vitro.
Dehousse V; Garbacki N; Jaspart S; Castagne D; Piel G; Colige A; Evrard B
Int J Biol Macromol; 2010 Apr; 46(3):342-9. PubMed ID: 20096725
[TBL] [Abstract][Full Text] [Related]
40. Co-delivery of SOX9 genes and anti-Cbfa-1 siRNA coated onto PLGA nanoparticles for chondrogenesis of human MSCs.
Jeon SY; Park JS; Yang HN; Woo DG; Park KH
Biomaterials; 2012 Jun; 33(17):4413-23. PubMed ID: 22425025
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
